SCHEMBL4341027

SCHEMBL4341027

NC(=O)C(c1cccs1)n1nc(-c2cc3ccccc3o2)c2c(F)c(C(=O)O)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.40
ALDH1A1 P00352 6/20 0.40
TDP1 Q9NUW8 1/20 0.40
MAPT P10636 7/20 0.37
POLB P06746 3/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 6/20 0.35
KMT2A Q03164 6/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PLAU P00749 2/20 0.35
KCNH2 Q12809 1/20 0.35
SCN5A Q14524 1/20 0.35
CSNK2A1 P68400 1/20 0.34
SMN1; SMN2 Q16637 5/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
MAPK1 P28482 2/20 0.33
TSHR P16473 1/20 0.33
LMNA P02545 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4329361 0.84 CYP1A2 (0.37) KDM4EALDH1A1MAPTHPGDMEN1
SCHEMBL4335926 0.82 IKBKB (0.35) PLAUKDM4C
SCHEMBL4346820 0.80 PTGER1 (0.40) KDM4EALDH1A1
SCHEMBL4331301 0.80 KDM4E (0.41) KDM4EALDH1A1TDP1MAPTPOLB
SCHEMBL4331228 0.75 KDM4E (0.36) KDM4EALDH1A1TDP1MAPTPOLB
SCHEMBL2864978 0.73 KDM4E (0.46) KDM4EALDH1A1TDP1MAPTPOLB
SCHEMBL4334570 0.69 KDM4E (0.39) KDM4EALDH1A1TDP1MAPTPOLB
SCHEMBL4331950 0.67 CTSA (0.37) GAA
SCHEMBL2872600 0.66 KDM4E (0.45) KDM4EALDH1A1TDP1MAPTPOLB
SCHEMBL2864981 0.66 KDM4E (0.39) KDM4EALDH1A1TDP1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDM4E 2531/4885ALDH1A1 1588/4885TDP1 3905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.